AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (October 13, 2005). doi:10.1152/ajpgi.00332.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/G609    most recent
00332.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peretti, N.
Right arrow Articles by Levy, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peretti, N.
Right arrow Articles by Levy, E.
Submitted on July 19, 2005
Accepted on September 27, 2005

Abnormal Intracellular Lipid Processing Contributes to Fat Malabsorption in Cystic Fibrosis Patients

Noel Peretti1, Claude C Roy2, Eric Drouin2, Ernest Seidman2, Pierre Brochu3, Georges Casimir4, and Emile Levy1*

1 Nutrition, CHU-Ste-Justine, Montreal, Quebec, Canada
2 Pediatrics, CHU-Ste-Justine, Montreal, Quebec, Canada
3 Pathology, CHU-Ste-Justine, Montreal, Quebec, Canada
4 Hopital Universitaire des Enfants Reine Fabiola, Bruxelles, Bruxelles, Belgium

* To whom correspondence should be addressed. E-mail: emile.levy{at}recherche-ste-justine.qc.ca.

A common feature of cystic fibrosis (CF) is the functional derangement of the exocrine pancreas, which affects output of pancreatic lipase. This condition results in severe dietary malabsorption due to the poor hydrolysis of triacylglycerol (TG) in the lumen of the small intestine. Despite the benefits of pancreatic enzyme supplements, persistent intestinal fat malabsorption characterizes patients with CF. The aim of the current investigation was to determine whether defects in the intracellular phase of lipid transport occur in this pathophysiology in addition to the known disturbed digestive processes. Our hypothesis was tested by incubating intestinal biopsies from 6 CF and 6 healthy subjects with radiolabelled lipid and protein precursors. Lipid esterification and secretion were markedly decreased by 22-31% and 38-42%, respectively, in CF as noted by the low incorporation of (14C)-palmitic acid into TGs, phospholipids and cholesteryl esters in patients duodenal explants and culture media compared with controls (100%). Accordingly, the output of TG-rich lipoproteins was substantially reduced (p<0.05) and a similar trend was observed for high-density lipoproteins. Since intestinal lipoprotein assembly/secretion shows an absolute requirement for apolipoprotein (apo) B-48, radioactive labeling experiments were performed and they demonstrated a significantly (p<0.05) diminished synthesis of apo B-48 (40%) and apo A-I (30%). Given the critical role of microsomal triglyceride transfer protein in the formation of apo B-containing lipoproteins, its activity was determined and not found to be altered in CF intestinal tissue. Taken together, these results suggest that CF malabsorption may also be caused by defects in mucosal mechanisms leading to abnormal lipoprotein delivery into the blood circulation.




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. C. De Lisle
Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G104 - G111.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.